SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors Inc on August 6, 2025. The filing serves as a Regulation FD disclosure to furnish Supplemental Information for the quarter ended June 30, 2025. The company is incorporated in Maryland and its common stock trades on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced "Supplemental Information" document (Exhibit 99.1) hosted on the company's website, which is not included in the provided text.
Material Changes
No material changes versus prior periods are detailed in the text of this Form 8-K. The document acts solely as a notice that supplemental data for the second quarter of 2025 is available.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Investors must refer to the attached Exhibit 99.1 for any such disclosures.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended June 30, 2025, by accessing Exhibit 99.1 on the company website (www.nhireit.com).
- Confirm the accuracy of the supplemental information against the company's official press releases or earnings call transcripts.
- Review the full text of Exhibit 99.1 for any updates on debt levels, liquidity positions, or operational risks not summarized in this 8-K.